William Blair Issues Negative Estimate for MaxCyte Earnings
MaxCyte, Inc. (NASDAQ:MXCT – Free Report) – Equities researchers at William Blair lowered their Q2 2025 earnings estimates for shares of MaxCyte in a report issued on Thursday, May 8th. William Blair analyst M. Larew now forecasts that the company will post earnings per share of ($0.11) for the quarter, down from their previous forecast […]
